Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment

Introduction: Conventional cancer treatment, including surgery, chemotherapy, and radiotherapy, may not be sufficient to eradicate all malignant cells and prevent recurrence. Intensive treatment often leads to a depressed immune system, drug resistance, and toxicity, hampering the treatment outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooi, Soo Liang, McMullen, Debbie, Golombick, Terry, Nut, Dipl, Pak, Sok Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041933/
https://www.ncbi.nlm.nih.gov/pubmed/29037071
http://dx.doi.org/10.1177/1534735417735379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041933/
https://www.ncbi.nlm.nih.gov/pubmed/29037071
http://dx.doi.org/10.1177/1534735417735379

Ejemplares similares